Simón Serrano, S.; Tavecchio, M.; Mallik, J.; Grönberg, A.; Elmér, E.; Kifagi, C.; Gallay, P.; Hansson, M.J.; Massoumi, R.
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma. Cancers 2022, 14, 4553.
https://doi.org/10.3390/cancers14194553
AMA Style
Simón Serrano S, Tavecchio M, Mallik J, Grönberg A, Elmér E, Kifagi C, Gallay P, Hansson MJ, Massoumi R.
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma. Cancers. 2022; 14(19):4553.
https://doi.org/10.3390/cancers14194553
Chicago/Turabian Style
Simón Serrano, Sonia, Michele Tavecchio, Josef Mallik, Alvar Grönberg, Eskil Elmér, Chamseddine Kifagi, Philippe Gallay, Magnus Joakim Hansson, and Ramin Massoumi.
2022. "Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma" Cancers 14, no. 19: 4553.
https://doi.org/10.3390/cancers14194553
APA Style
Simón Serrano, S., Tavecchio, M., Mallik, J., Grönberg, A., Elmér, E., Kifagi, C., Gallay, P., Hansson, M. J., & Massoumi, R.
(2022). Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma. Cancers, 14(19), 4553.
https://doi.org/10.3390/cancers14194553